ClinicalTrials.Veeva

Menu

The Effect of Recognition and Expression of Emotions Program Applied to Schizophrenia Patients

S

Sinop University

Status

Completed

Conditions

Alexithymia
Emotion, Expressed
Schizophrenia

Treatments

Behavioral: Emotions Recognition and Expression

Study type

Interventional

Funder types

Other

Identifiers

NCT05662137
sınopUadeviye-1

Details and patient eligibility

About

As a result of the positive and negative symptoms that occur in schizophrenia, patients with schizophrenia may experience negative emotions more frequently than individuals with other mental problems. Since these emotions can trigger psychotic symptoms, there is a need to develop effective emotion regulation strategies to be applied to patients with schizophrenia.

Aim: In this study, it was aimed to examine the effect of emotion recognition and expression program on alexithymia and emotion expression in patients with schizophrenia.

Full description

Method: Fifty schizophrenic patients who regularly receive outpatient treatment at Sinop Community Mental Health Center will form the universe of the study. Individuals over the age of 18 who have schizophrenia, do not have mental retardation, have no comprehension and hearing problems, have insight, and are in remission will be included in the study. Individuals who meet the study criteria will be divided into experimental and control groups as 22 experimental and 22 control groups. The emotion recognition and expression program prepared by the researchers in line with the literature will be applied to the experimental group for 8 weeks. Personal Information Form, Expression of Emotions Scale, Positive and Negative Syndrome Scale and Toronto Alexithymia Scale were planned to be applied to the experimental and control groups in the pre-test, post-test and follow-up. Follow-up will take place one month after the last session of the study. Psychosocial interventions applied to patients with schizophrenia help patients to increase their level of well-being and quality of life, to decrease negative and positive symptoms by increasing social functionality, to participate in social life, to be an autonomous individual and to prevent stigma. In line with psychosocial interventions, it is thought that the this program to be applied to the patients in this study will basically contribute to the individual patients' ability to recognize their emotions, discuss their emotions, regulate their emotion intensities, and express their emotions. Due to the impact that this program will have on the individual, it is believed that it will have positive results not only for schizophrenia patients, but also for the individuals with whom the patients interact, their relatives and even the society.

Enrollment

36 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient who had received a diagnosis of schizophrenia and comes to the Community Mental Health Center regularly,
  • Being able to read and communicate
  • Being 18 years of age or older,
  • Not having mental retardation,
  • Not having insight, understanding, hearing problems,
  • Being in remission,
  • Volunteering to study

Exclusion criteria

  • Not diagnosed with clinical schizophrenia,
  • Being under the age of 18,
  • Having mental retardation,
  • Having no insight,
  • Not understanding and hearing,
  • Not in remission
  • Refusing to participate in the study
  • Stop studying at any stage of the study

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

36 participants in 2 patient groups

Control group
No Intervention group
Description:
At the beginning of the study, data collection tools Personal Information Form, Expression of Emotions Scale, Toronto Alexithymia Scale, Positive and Negative Syndrome Scale will be applied to the control group. No intervention will be made in the control group. Measurement tools will be applied for the posttest. Emotional Expression Scale, Toronto Alexithymia Scale and Positive and Negative Syndrome Scale will be reapplied 1 month after the last session.
Experimental group
Experimental group
Description:
Emotion recognition and expression program is aimed to be carried out in 8-week sessions for schizophrenia patients included in the experimental group. Personal Information Form, Expression of Emotions Scale, Toronto Alexithymia Scale, Positive and Negative Syndrome Scale will be applied to the experiment. The principal investigator will lead the structured group sessions as the group leader. The principal investigator will lead the structured group sessions as the group leader. Each group is planned to be 60-90 minutes. Before sessions, participants are taken from their previous session's emotions so far. Homework is discussed by providing recall of the topic from the previous session, and then the current topic is moved on. At the end of each session, a general summary and evaluation is made. After the sessions in the research, measurement tools will be applied for the posttest. It will be reapplied 1 month after the last session.
Treatment:
Behavioral: Emotions Recognition and Expression

Trial contacts and locations

1

Loading...

Central trial contact

Berna ERSOY ÖZCAN, PhD; Adeviye AYDIN, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems